Observe the clinical effect of insulin detemir and insulin aspart in the subcutaneous treatment of T2DM

Objective To observe the clinical efficacy of insulin detemir and insulin aspart in the subcutaneous treatment of type Ⅱ diabetes. Methods 140 patients with type Ⅱ diabetes in our hospital were randomly divided into observation group and control group, each group had 70 cases.Patients in the control group were given subcutaneously neutral protamine zinc insulin(NPH) at bedtime and subcutaneous insulin aspart before meals; Patients in the observation group were given subcutaneously insulin detemir at bedtime and subcutaneous insulin aspart before meals.Strictly monitored blood glucose and adverse reactions of the two groups. Results After the treatment,the total glucose standard of the observation group was significantly lower than the control group there had statistically significant(P 0.05). Conclusion The efficacy of glycemic control of insulin detemir and insulin aspart is as NPH and insulin aspart, blood glucose compliance faster,insulin amount smaller, blood sugar remain more stable.